Effects of Pseudevernia furfuracea (L.) Zopf on Helicobacter pylori induced gastritis in rats: anti- Helicobacter pylori and anti gastritis properties

We evaluated the antimicrobial and host-directed effects of Pseudevernia furfuracea (L.) Zopf (P. furfuracea) against Helicobacter pylori (H. pylori) associated gastritis. The acetone extract inhibited H. pylori growth in vitro, with a minimum inhibitory concentration (MIC) of 15.625 µg/mL, and modestly reduced pre-formed biofilms. In a rat model of indomethacin- and H. pylori induced gastritis, oral P. furfuracea treatment lowered gastric bacterial load and urease activity, shifted the cytokine profile toward an anti-inflammatory pattern (reduced interleukin-1β [IL-1β] and restored interleukin-10 [IL-10]), improved oxidative status (decreased malondialdehyde [MDA] and total oxidant status [TOS], increased reduced glutathione [GSH] and total antioxidant status [TAS]), and downregulated hypoxia-inducible factor-1α (HIF-1α) and transforming growth factor-β (TGF-β) transcripts. These molecular and biochemical changes were accompanied by better preservation of gastric mucosal architecture and reduced inflammatory cell infiltration. Overall, P. furfuracea exhibited a dual profile, combining direct anti H. pylori activity with mucosa-protective, host-directed effects. These findings support further development of standardized P. furfuracea preparations, including mechanistic, phytochemical, and dose–response studies, as potential adjuncts to conventional H. pylori therapies. Thirty-six Wistar albino rats were equally divided into 6 groups. Group 1 was treated with NaCl (1). Rats in Groups 2-6 with GU were given indomethacin (5 mg/kg) by gavage for 5 days (2). Rats in Groups 3, 5 and 6 with gastritis were given 1 mL of H. pylori suspension prepared as 10⁸-109 CFU/mL by gavage twice daily for 7 days (3). Rats in groups 4 and 5 received P. furfuracea (15 µg/rat/day) by gavage once daily (4). Group 6 received standard drugs (amoxicillin, 50 mg/kg; clarithromycin, 25 mg/kg; omeprazole, 20 mg/kg) once daily (5). After treatment (6), all animals in the groups were euthanized and gastric tissues were removed (7).

Authors

Institutions

Publication Details

Journal
Folia Microbiologica
Published
2026-02-05
DOI
https://doi.org/10.1007/s12223-026-01428-y
Primary Topic
Helicobacter pylori-related gastroenterology studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effects of Pseudevernia furfuracea (L.) Zopf on Helicobacter pylori induced gastritis in rats: anti- Helicobacter pylori and anti gastritis properties

Güllü Kaymak, Ayşe Koçak, S. Simsek, Meliha Koldemir Gündüz et al.
Folia Microbiologica
Helicobacter pylori-related gastroenterology studies
article

Effects of Pseudevernia furfuracea (L.) Zopf on Helicobacter pylori induced gastritis in rats: anti- Helicobacter pylori and anti gastritis properties

Güllü Kaymak, Ayşe Koçak, S. Simsek, Meliha Koldemir Gündüz, Birkan AÇIKGOZ, Elif AYDIN
article en

Abstract

We evaluated the antimicrobial and host-directed effects of Pseudevernia furfuracea (L.) Zopf (P. furfuracea) against Helicobacter pylori (H. pylori) associated gastritis. The acetone extract inhibited H. pylori growth in vitro, with a minimum inhibitory concentration (MIC) of 15.625 µg/mL, and modestly reduced pre-formed biofilms. In a rat model of indomethacin- and H. pylori induced gastritis, oral P. furfuracea treatment lowered gastric bacterial load and urease activity, shifted the cytokine profile toward an anti-inflammatory pattern (reduced interleukin-1β [IL-1β] and restored interleukin-10 [IL-10]), improved oxidative status (decreased malondialdehyde [MDA] and total oxidant status [TOS], increased reduced glutathione [GSH] and total antioxidant status [TAS]), and downregulated hypoxia-inducible factor-1α (HIF-1α) and transforming growth factor-β (TGF-β) transcripts. These molecular and biochemical changes were accompanied by better preservation of gastric mucosal architecture and reduced inflammatory cell infiltration. Overall, P. furfuracea exhibited a dual profile, combining direct anti H. pylori activity with mucosa-protective, host-directed effects. These findings support further development of standardized P. furfuracea preparations, including mechanistic, phytochemical, and dose–response studies, as potential adjuncts to conventional H. pylori therapies. Thirty-six Wistar albino rats were equally divided into 6 groups. Group 1 was treated with NaCl (1). Rats in Groups 2-6 with GU were given indomethacin (5 mg/kg) by gavage for 5 days (2). Rats in Groups 3, 5 and 6 with gastritis were given 1 mL of H. pylori suspension prepared as 10⁸-109 CFU/mL by gavage twice daily for 7 days (3). Rats in groups 4 and 5 received P. furfuracea (15 µg/rat/day) by gavage once daily (4). Group 6 received standard drugs (amoxicillin, 50 mg/kg; clarithromycin, 25 mg/kg; omeprazole, 20 mg/kg) once daily (5). After treatment (6), all animals in the groups were euthanized and gastric tissues were removed (7).

Folia Microbiologica
University of Health Science (KH), Kütahya Dumlupınar Üniversitesi (TR), Ağrı İbrahim Çeçen University (TR), Universidad CES (CO), Department of Health Services (NP), Kutahya Saglik Bilimleri Universitesi
Openalex Percentile: Top 65%
Helicobacter pylori-related gastroenterology studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.